Novel genetic mutation in the background of Carney complex

Csaba Halászlaki1, István Takács, Henriett Butz

  • 11st Department of Medicine, Semmelweis University, Korányi Sándor u. 2/A, Budapest 1083, Hungary. drhalaszlaki@gmail.com

Insights

Carney complex, a rare genetic disorder, is often caused by protein kinase A mutations. Genetic testing is crucial for diagnosing this condition and monitoring patients for new symptoms.

Area of Science:

  • Genetics
  • Endocrinology
  • Oncology

Background:

  • Carney complex is a rare autosomal dominant disorder.
  • It is primarily caused by inactivating mutations in the regulatory subunit of protein kinase A.
  • Associated conditions include atrial myxomas, skin lesions, breast tumors, and endocrine overactivity, notably primary pigmented nodular adrenocortical disease.

Observation:

  • A 53-year-old female patient with a history of atrial myxomas, thyroid tumor, breast cancer, and Cushing’s syndrome due to adrenal adenoma was studied.
  • Genetic analysis identified a novel splice mutation (ivs2-1G>A) in intron 2 of the regulatory subunit of protein kinase A.
  • Her heterozygous twins were screened, and one carried the identical mutation.

Findings:

  • A novel inactivating mutation in the regulatory subunit of protein kinase A was identified in a patient with Carney complex.
  • This mutation was also found in one of the patient's heterozygous twins.
  • Primary pigmented nodular adrenocortical disease was noted as a specific endocrine manifestation.

Implications:

  • Genetic confirmation of Carney complex is vital for patient management.
  • Early diagnosis facilitates close monitoring and identification of potential new manifestations.
  • While no specific treatment exists, genetic screening aids in proactive healthcare for affected individuals and families.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Mutations01:39

Mutations

Overview
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...